Skip to content
AtessiaAtessia Life Science Advisors
  • Home
  • Expertise
  • Services
    • Medicines
      • Exploitant – Pharmaceutical establishment
        • Find / Open a French “Exploitant” pharmaceutical company
        • Activities related to quality
        • External communications
        • Relation betwenn healthcare professionals & Compliance
        • Pharmacovigilance
      • Regulatory & Pharmaceutical Strategy
      • Research & Development Consulting
      • Marketing authorisation
        • Registration: Drafting & Submitting MA files
        • Post-MA lifecycle management
    • Medical devices
    • Consulting subscription
    • Audits
    • Regulatory monitoring
    • Training
    • Atessia Vigilances
  • Strengths
  • News
    • Company
    • Events
  • Blog
  • Join Atessia
  • Contact
  • English
    • Français
    • English

Blog

_Blog

The Jardé Law and Research Involving Human Subjects (RIPH): How Are Pharmaceutical Companies Affected? 

Lire la suite »
_Blog

The Excellence of ATESSIA’s CMC: Your Partner in Technical and Regulatory Affairs

Lire la suite »
_Blog

The Post-Approval Change Management Protocol or “PACMP” 

Lire la suite »
_Blog

What are Good Manufacturing Practices (GMP) ? 

Lire la suite »
_Blog

What are CEPs ?

Lire la suite »
_Blog

What is the European Pharmacopeia ?

Lire la suite »
_Blog

What future for therapeutic cannabis in France?

Lire la suite »
_Blog

Poisonous Substances: What Use within the Pharmaceutical Industry? 

Lire la suite »
_Blog

Therapeutic patient education versus learning programs: what is role for the pharmaceutical industry?

Lire la suite »
_Blog

What is the Requirement for Transparency of Conflicts of Interest with Healthcare Professionals in France?

Lire la suite »
_Blog

What are the mechanisms for early and compassionate access in France?  

Lire la suite »
_Blog

What about the classification of Marketing Authorization variations? 

Lire la suite »
Page1 Page2 Page3 Page4

ATESSIA, Life Science Advisors
3, Rue d’Uzès – 75002 PARIS
hello@atessia.fr
+33 1.70.22.66.19

Atessia Life Science Advisors

Follow-us

Legal notices

Terms and Conditions of Sale

ATESSIA SAS with capital of €5,000.00 I RCS PARIS 827 777 319

Copyright © 2021 | Powered by Atessia